
Keywords: سینومینین هیدروکلراید; microarray; transdermal drug delivery; skin; permeability; pharmacokinetics; biocompatibility; CS; chondroitin sulfate; DM; dissolving microneedle; GMO; glyceryl monooleate; H1; normal hexagonal phases; H2; reversed hexagonal phases; L1; normal micelles;